Skip to content

PerceptiMed adds to sales team

PerceptiMed has named three industry veterans to its sales team. The appointments of  A.J. Lipka, Jonathan Jacobs and Lori Lewonski expand the company’s sales and marketing organization to eight members.

Table of Contents

MOUNTAIN VIEW, Calif. —  PerceptiMed has named three industry veterans to its sales team. The appointments of  A.J. Lipka, Jonathan Jacobs and Lori Lewonski expand the company’s sales and marketing organization to eight members.

A.J. Lipka

Lipka, Jacobs and Lewonski have extensive experience selling software, technology and services within the health care/pharmacy business-to-consumer and business-to-business markets, particularly to pharmacy operations.

Lipka previously held positions with Cardinal Health’s Telepharm, McKesson Pharmacy Systems, Managed Healthcare Associates, and DaVita Rx. He will cover Texas and surrounding states.

“PerceptiMed’s proprietary technology prevents medication errors and saves lives,” Lipka stated. “I am excited to be included in a stellar sales team and to be part of the continuous development and enhancement of patient safety technology.”

Jonathan Jacobs

Jacobs previously was with Opus-Core, Opus-ISM and Speed Script. He will cover northeastern states including New York.

Lewonski previously was with PBI, Managed Healthcare Associates and GeriMed. She will cover  the mountain states, including Colorado.

Lori Lewonski

“All three of these individuals have proven themselves to be experienced, knowledgeable and successful sales executives in pharmacy technology and services. We are absolutely thrilled to have them join our team,” said PerceptiMed vice president of sales and marketing Terry Cater. “Adding A.J., JJ and Lori will continue the momentum of PerceptiMed’s commitment to delivering the right prescriptions to the right patients in the right dosage, every time.”

PerceptiMed’s technology is utilized in retail pharmacies, hospitals, and long-term care facilities  to enhance accuracy and patient safety.

Comments

Latest